in partnership with Embrapii (Brazilian Industrial Research and Innovation Company), launches this Thursday (26), a set of projects for the SUS to combat , and multiple sclerosis.
There will be R$90 million to expand access to advanced therapies and diagnostics and produce strategic medicines. R$73 million will come from the ministry and Embrapii and another R$17 million in return from seven companies.
Among the projects, in vivo engineering of CAR-T lymphocytes for the treatment of cancer, a platform for monitoring diabetic patients with photonic, electrical and artificial intelligence techniques and the development of a biopharmaceutical for the treatment of Multiple Sclerosis.
The announcement will be made during a ceremony to announce actions that seek r.
The Minister of S, (PT), says that the objective is to reduce dependence on imported solutions. “We are expanding the national capacity to develop technologies for the treatment of various diseases, reducing external dependence in the production of highly complex medicines and guaranteeing greater access to the population through the SUS”, he stated.
LINK PRESENT: Did you like this text? Subscribers can access seven free accesses from any link per day. Just click the blue F below.
your subscription could be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (). You can also download our free app at or to receive alerts for the day’s top news. Your subscription helps us provide independent, quality journalism. Thanks!
your subscription is worth a lot
More than 180 reports and analyzes published every day. A team with more than 200 columnists and bloggers. Professional journalism that monitors public authorities, conveys useful and inspiring news, counteracts the intolerance of social media and draws a clear line between truth and lies. How much does it cost to help produce this content?
